Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis-Reference-Cited by-同舟云学术

Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis

Published:2001-12 Issue:6 Volume:108 Page:1012-1020
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Kanegane Hirokazu,Futatani Takeshi,Wang Yue,Nomura Keiko,Shinozaki Kentaro,Matsukura Hiroyoshi,Kubota Takeo,Tsukada Satoshi,Miyawaki Toshio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Immunodeficiency disorders: general considerations;Conley,1996

2. Genetic basis of abnormal B cell development;Conley;Curr Opin Immunol,1998

3. X-linked agammaglobulinemia. A clinical and molecular analysis;Ochs;Medicine,1996

4. Molecular and cellular aspects of X-linked agammaglobulinemia;Sideras;Adv Immunol,1995

5. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia;Tsukada;Cell,1993

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E41K mutation activates Bruton’s tyrosine kinase by stabilizing an inositol hexakisphosphate-dependent invisible dimer;Journal of Biological Chemistry;2024-08

2. Discordant Phenotypes of Nephritis in Patients with X-linked Agammaglobulinemia;Journal of Clinical Immunology;2024-07-25

3. Flow cytometry-based diagnostic approach for inborn errors of immunity: experience from Algeria;Frontiers in Immunology;2024-07-12

4. Effective Management of XLA Associated Enteropathy with Vedolizumab Monotherapy;Journal of Clinical Immunology;2024-06-19

5. E41K Mutation Activates Bruton’s Tyrosine Kinase by Stabilizing an Inositol Hexakisphosphate dependent Invisible Dimer;2024-01-23